查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2017588

醫療保健領域人工智慧市場：按類型、交付管道、疾病類別、應用、部署模式和最終用戶分類——2026-2030年全球市場預測

Artificial Intelligence in Healthcare Market by Type, Delivery Channel, Disease Category, Application, Deployment Mode, End-User - Global Forecast 2026-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年醫療領域的人工智慧 (AI) 市場價值為 145.5 億美元，預計到 2025 年將成長至 170.1 億美元，複合年成長率為 18.13%，到 2030 年將達到 395.6 億美元。

主要市場統計數據
基準年 2024 145.5億美元
預計年份：2025年 170.1億美元
預測年份 2030 395.6億美元
複合年成長率 (%) 18.13%

簡要概述人工智慧如何改變臨床護理、工作流程和研究過程，同時仍需要管治和臨床醫生的信任。

人工智慧正迅速改變醫療保健的提供、研究和管理方式，它能夠實現更精準的診斷、更有效率的工作流程，並開闢新的治療方法途徑。在臨床實踐中，人工智慧驅動的工具透過影像模式識別、基因組分析和即時病患監測，為臨床醫生提供決策支援。同時，人工智慧也正在利用商業應用最佳化行政工作流程，簡化計費和預約管理，並透過快速資訊搜尋和持續護理縮短治療時間。先進演算法與豐富的臨床資料集的整合，使各機構能夠從概念驗證（PoC）試點階段過渡到影響跨學科診療路徑的整合解決方案。

演算法精度、邊緣監測、影像分析和雲端基礎設施的進步如何改變臨床實踐和商業性夥伴關係。

在演算法能力、資料可用性和雲端原生基礎設施的推動下，醫療保健領域正經歷著一場變革。邊緣運算和穿戴式裝置使得在傳統醫療環境之外也能病患監測成為可能，從而產生適用於近即時分析的高速感測器和生命徵象數據。同時，影像分析和電腦視覺技術的進步正在提昇放射學和病理學的診斷能力，實現疾病表現型的早期檢測和更精準的表徵。此外，人工智慧驅動的藥物發現平台和基因組分析正在縮短研發週期，並使標靶治療的開發更加數據驅動和靈活。

評估關稅和貿易政策的波動如何對醫療保健人工智慧生態系統內的供應鏈帶來壓力，如何影響部署選擇，以及如何促進製造業的韌性。

近期關稅趨勢和貿易政策的變化為人工智慧醫療技術的供應鏈規劃和供應商策略帶來了新的變數。影響硬體組件（例如監控設備、機器人和穿戴式設備組件）的關稅可能導致醫療服務提供者和原始設備製造商 (OEM) 的成本增加和採購週期延長。這些變化凸顯了本地化生產、供應商網路多元化和策略性庫存規劃的重要性，以確保關鍵設備的持續供應。同時，影響資料中心硬體和網路元件的關稅正在影響私有雲端部署和邊緣運算解決方案的經濟效益，促使各組織重新評估其在公共雲端、私有雲端、混合雲和本地部署架構中的部署模式。

透過進行全面的細分，明確類型、交付管道、資料類別、臨床應用、部署模型和最終用戶，我們可以製定有針對性的部署策略。

精細化的細分框架對於理解人工智慧在醫療保健領域的機會和應用路徑至關重要。根據類型，所提供的服務可分為硬體、服務和軟體。硬體包括監測設備、機器人和穿戴式設備，這些設備旨在收集臨床訊號或輔助完成手術操作。服務包括諮詢服務、實施和整合服務以及維護和支援服務，這些服務能夠確保成功實施和生命週期管理。軟體包括臨床決策支援系統、資料管理和分析工具、藥物研發平台、醫學影像平台以及自然語言處理應用程式，這些應用程式能夠從各種資料來源中提取臨床資訊。

美洲、歐洲、中東和非洲以及亞太地區的趨勢和政策環境如何影響醫療保健領域的人工智慧採用、檢驗和商業化策略。

區域趨勢塑造了人工智慧在醫療保健領域的應用路徑和監管預期，美洲、歐洲、中東和非洲以及亞太地區的驅動力各不相同。在美洲，集中化的醫療服務網路和成熟的支付體系創造了有利於臨床檢驗和報銷的良好環境，從而加速了企業級應用。同時，充滿活力的Start-Ups生態系統和領先的研究機構正在推動藥物研發和影像分析領域的創新。跨境合作以及與雲端供應商的夥伴關係經常被用於支持可擴展性和轉化研究計畫。

主要企業如何將臨床檢驗、互通性、策略夥伴關係和服務主導模式結合，以實現服務差異化並擴大其服務的應用？

該領域的主要企業正朝著差異化策略靠攏，這些策略融合了技術深度、臨床專長和監管洞察力。他們正投資於平台互通性，以實現與電子健康記錄系統和影像檔案庫的整合，同時建立針對腫瘤學、心臟病學和神經病學等領域的特定模型，以加速臨床應用。與大學附屬醫院和研究機構建立策略夥伴關係十分普遍，這為他們提供了獲取精選資料集、臨床檢驗隊列和真實世界數據所需的資源，從而支持監管申報和與保險公司的諮詢。同時，與雲端服務供應商和系統整合商的合作也幫助供應商擴展部署規模，並確保強大的資料安全性和合規性。

醫療保健領導者採取切實可行的步驟，以協調資料管治、臨床檢驗、供應鏈彈性和人才準備，從而採用人工智慧。

產業領導者應制定切實可行、以證據為基礎的藍圖，使技術投資與臨床優先事項和營運限制保持一致。首先，應優先考慮資料管治和互通性工作，以確保高品質、具代表性的資料集，並與電子健康記錄和影像系統無縫整合。其次，應設計切實可行、可重複且全面的臨床檢驗研究，以期最終實現實際的臨床應用，而非僅關注孤立的表現指標。在採購和供應鏈規劃方面，應實現供應商多元化，評估關鍵硬體組件的近岸外包方案，並評估關稅對醫療設備供應和整體擁有成本的影響。

採用嚴謹的混合方法研究途徑，結合一手訪談、二手文獻、檢驗、細分映射和專家檢驗。

本報告整合了結構化、系統化的研究方法所得出的洞見，該方法結合了初步和二次調查、專家諮詢以及反覆檢驗。初步研究包括對臨床負責人、技術主管和供應鏈經理的深入訪談，以了解部署的實際情況和策略重點。二次研究包括同儕審查文獻、監管指導文件、技術白皮書和供應商產品資料，以闡明技術能力和證據標準。資料三角測量技術用於協調不同觀點，並識別不同資訊來源的通用主題。

將人工智慧創新負責任地轉化為永續的臨床和營運影響，需要整合證據、互通性並加強跨部門合作。

人工智慧既代表著醫療保健產業的技術飛躍，也帶來了巨大的組織挑戰。其最具前景的應用在於顯著改善臨床決策、簡化行政流程並加強病患監測，同時也要遵守監管和倫理框架。成功實施取決於可靠的臨床證據、與臨床醫生工作流程的無縫整合、穩健的供應鏈以及前瞻性的商業化策略。區域監管差異和貿易政策趨勢增加了複雜性，但也為在地化和策略夥伴關係創造了機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療領域的人工智慧市場：按類型分類

  • 硬體
    • 監控設備
    • 機器人技術
    • 穿戴式裝置
  • 服務
    • 諮詢服務
    • 實施和整合服務
    • 維護和支援
  • 軟體
    • 臨床決策支援系統
    • 數據管理與分析
    • 藥物發現平台
    • 醫學影像診斷平台
    • 自然語言處理應用

第9章：按交付管道分類的醫療領域人工智慧市場

  • 數位平台
  • 現場服務
  • 遠端服務

第10章：按疾病分類的醫療領域人工智慧市場

  • 心血管疾病
  • 皮膚病
  • 消化系統疾病
  • 神經系統疾病
  • 腫瘤疾病
  • 整形外科疾病
  • 呼吸系統疾病

第11章：醫療領域的人工智慧市場：按應用領域分類

  • 管理工作流程
    • 預約管理
    • 帳單管理
    • 合規管理
    • 記錄管理
  • 診斷
    • 臨床試驗
    • 基因檢測
    • 病理診斷
    • 放射診斷
  • 病患監測
    • 重症加護病房監測
    • 遠端患者監護
    • 生命徵象監測
  • 治療管理
    • 藥物治療最佳化
    • 個人化醫療
    • 放射治療
    • 機器人手術

第12章：醫療領域的人工智慧市場：依部署模式分類

  • 基於雲端的
  • 混合
  • 現場

第13章：醫療領域的人工智慧市場：依最終用戶分類

  • 學術和研究機構
  • 診斷中心
  • 醫院和醫療保健機構
  • 製藥和生物技術公司

第14章：醫療領域的人工智慧市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：醫療領域的人工智慧市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：醫療領域的人工智慧市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國醫療保健產業的人工智慧市場

第18章：中國醫療保健產業的人工智慧市場

第19章 競爭情勢

  • 2024年市場集中度分析
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2024 年
  • 2024年產品系列分析
  • 基準分析，2024 年
  • Amazon Web Services, Inc.
  • GE Healthcare
  • Google, LLC by Alphabet, Inc.
  • International Business Machines Corporation
  • IQVIA Holdings Inc.
  • Koninklijke Philips NV
  • Microsoft Corporation
  • Nano-X Imaging Ltd.
  • Oracle Corporation
  • Salesforce, Inc.
  • Siemens Healthineers AG
Product Code: MRR-031BF22F9550

The Artificial Intelligence in Healthcare Market was valued at USD 14.55 billion in 2024 and is projected to grow to USD 17.01 billion in 2025, with a CAGR of 18.13%, reaching USD 39.56 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 14.55 billion
Estimated Year [2025] USD 17.01 billion
Forecast Year [2030] USD 39.56 billion
CAGR (%) 18.13%

A concise framing of how artificial intelligence is transforming clinical care, operational workflows, and research pathways while requiring governance and clinician trust

Artificial intelligence is rapidly reshaping the contours of healthcare delivery, research, and administration by enabling higher-precision diagnostics, more efficient workflows, and novel pathways for therapeutic discovery. In clinical settings, AI-driven tools are augmenting clinician decision-making through pattern recognition in imaging, genomic interpretation, and real-time patient monitoring. Concurrently, operational applications leverage AI to optimize administrative workflow, streamline billing and appointment scheduling, and reduce time-to-treatment by enabling faster information retrieval and continuity of care. The convergence of advanced algorithms with richer clinical data sets has allowed organizations to move from proof-of-concept pilots to integrated solutions that can influence care pathways across specialties.

However, translating AI potential into routine practice requires managing complex intersections of data governance, interoperability, and clinical validation. Effective adoption hinges not only on technological robustness but also on clinician trust, regulatory alignment, and demonstrable improvements in patient outcomes. Given the diversity of AI modalities-from clinical decision support systems to natural language processing and robotic surgery-stakeholders must evaluate solutions against clinical readiness, workforce implications, and ethical considerations. In this context, healthcare leaders must balance rapid innovation with stringent evaluative frameworks to ensure patient safety, equitable deployment, and sustainable integration within existing care ecosystems.

How advancements in algorithmic precision, edge monitoring, imaging analytics, and cloud infrastructure are reshaping clinical practice and commercial partnerships

The landscape of healthcare is undergoing transformative shifts driven by advances in algorithmic capability, data availability, and cloud-native infrastructure. Edge and wearable devices are enabling continuous patient monitoring outside traditional settings, which in turn generates high-velocity sensor and vital sign data suitable for near-real-time analytics. Simultaneously, improvements in imaging analytics and computer vision have elevated diagnostic performance for radiology and pathology, enabling earlier detection and more precise characterization of disease phenotypes. At the same time, AI-assisted drug discovery platforms and genomic analytics are compressing research timelines and making targeted therapy development more data-driven and adaptive.

These technological shifts are accompanied by systemic changes in delivery and commercialization. Health systems are increasingly partnering with software and services providers to accelerate integration, while payers show growing interest in reimbursement models that reward outcomes tied to validated AI tools. Interoperability initiatives and standards for clinical data exchange are gaining traction, lowering the friction for multi-source data synthesis. As a result, the competitive landscape is expanding beyond traditional medtech and software vendors to include cloud providers, specialty analytics firms, and clinical labs, each bringing distinct capabilities. Going forward, the most impactful innovations will be those that combine robust clinical validation with seamless workflow integration and clear value propositions for clinicians and patients.

Assessment of how evolving tariffs and trade policy create supply chain pressures, influence deployment choices, and incentivize manufacturing resilience in healthcare AI ecosystems

Recent tariff movements and changes in trade policy have introduced new variables into supply chain planning and vendor strategy for AI-enabled healthcare technologies. Tariffs that affect hardware components, such as monitoring equipment, robotics, and wearable device assemblies, can increase costs and elongate procurement cycles for providers and OEMs alike. These shifts place a premium on localized manufacturing, diversified supplier networks, and strategic inventory planning to maintain continuity of critical device availability. In parallel, tariffs that influence data center hardware and networking components can impact the economics of private cloud deployments and edge compute solutions, prompting organizations to reassess deployment modes between public cloud, private cloud, hybrid, and on-premise architectures.

Moreover, procurement teams are increasingly weighing the implications of trade policy on vendor selection, favoring partners with resilient supply chains and multi-region manufacturing footprints. Legal and compliance functions must also account for evolving import-export controls, especially where specialized components for medical imaging platforms or robotic surgery systems are sourced across jurisdictions. Consequently, healthcare organizations and technology vendors are recalibrating strategic sourcing, exploring nearshoring or onshoring options, and incorporating tariff sensitivity analyses into contractual negotiations, with the goal of minimizing operational disruption while preserving access to critical AI-enabled capabilities.

Comprehensive segmentation that delineates types, delivery channels, data categories, clinical applications, deployment modes, and end users to inform targeted adoption strategies

A nuanced segmentation framework is essential for understanding opportunities and implementation pathways across AI in healthcare. Based on Type, offerings can be categorized across Hardware, Services, and Software; hardware comprises monitoring equipment, robotics, and wearable devices designed to capture clinical signals or assist procedural tasks; services cover consulting services, deployment and integration services, and maintenance and support that enable successful implementation and lifecycle management; and software spans clinical decision support systems, data management and analysis tools, drug discovery platforms, medical imaging platforms, and natural language processing applications that extract clinical intelligence from diverse data sources.

Based on Delivery Channel, solutions are delivered through digital platforms, mobile applications, onsite services, remote services, and wearable devices, with mobile applications further segmented by operating environment into Android applications and iOS applications that determine integration and user experience considerations. Based on Organization Scale, adoption dynamics differ between large enterprises and small and medium enterprises, with larger systems often prioritizing integration at scale and SMEs emphasizing turnkey, lower-friction deployments. Based on Data Category, analytic approaches must accommodate genomic data, imaging data, semi-structured data, sensor data, structured data, and unstructured data; genomic data includes exome sequencing and whole genome sequencing datasets, while imaging data includes CT, MRI, and X-ray modalities that require specialized preprocessing and annotation workflows.

Based on Disease Category, AI applications address cardiovascular disorders, dermatological disorders, gastrointestinal disorders, neurological disorders, oncology disorders, orthopedic disorders, and respiratory disorders, each presenting unique diagnostic and therapeutic data patterns. Based on Application Area, implementations span administrative workflow, diagnostics, patient monitoring, and treatment management; administrative workflow includes appointment scheduling, billing management, compliance management, and record management, whereas diagnostics comprises clinical testing, genetic testing, pathology diagnostics, and radiology diagnostics; patient monitoring encompasses ICU monitoring, inpatient monitoring, remote patient monitoring, and vital sign monitoring; and treatment management covers drug therapy optimization, personalized medicine, radiation therapy, and robotic surgery. Based on Deployment Mode, environments are cloud-based, hybrid, and on-premise, with cloud-based options further differentiated into private cloud and public cloud to meet security and latency requirements. Finally, based on End User Type, primary adopters include diagnostic centers, hospitals, pharmaceutical companies, and research institutes, each of which demands distinct service levels, validation evidence, and regulatory documentation.

Regional dynamics and policy environments across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence adoption, validation, and commercialization strategies

Regional dynamics shape adoption pathways and regulatory expectations for AI in healthcare, with distinct drivers across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, concentrated healthcare delivery networks and established payer systems create an environment where clinical validation and reimbursement pathways can accelerate enterprise-scale deployments, while vibrant startup ecosystems and advanced research institutions drive innovation in drug discovery and imaging analytics. Cross-border collaborations and partnerships with cloud vendors are frequently leveraged to support scalability and translational research programs.

In Europe, Middle East & Africa, regulatory harmonization across certain jurisdictions and growing investment in digital health infrastructure influence deployment strategies, with an emphasis on privacy, data protection, and interoperability. Policymakers and health systems in these regions often prioritize robust governance frameworks and ethical AI use, prompting vendors to demonstrate compliance and explainability. Meanwhile, the Asia-Pacific region exhibits rapid adoption of mobile and remote monitoring solutions driven by large populations, heterogeneous care access, and strong public-private investment in health IT. Local manufacturing capacities, regulatory pathways, and regional partnerships are crucial considerations for vendors seeking to establish or expand footprints. Across regions, successful strategies balance compliance, clinical validation, and culturally appropriate patient engagement to ensure sustainable adoption and equitable benefits.

How leading firms combine clinical validation, interoperability, strategic partnerships, and service-led models to differentiate offerings and scale adoption

Leading organizations in this space are converging around differentiated strategies that combine technological depth with clinical domain expertise and regulatory acumen. Companies are investing in platform interoperability to enable integration with electronic health record systems and imaging archives, while concurrently building domain-specific models for oncology, cardiology, and neurology to accelerate clinical adoption. Strategic partnerships with academic medical centers and research institutes are common, enabling access to curated datasets, clinical validation cohorts, and real-world evidence necessary to support regulatory submissions and payer discussions. In parallel, alliances with cloud providers and systems integrators help vendors scale deployments and ensure robust data security and compliance.

Commercial strategies increasingly emphasize outcome-oriented value propositions, wherein vendors demonstrate how AI tools improve clinical workflows, reduce diagnostic variability, or enhance patient monitoring without adding clinician burden. Service models augment software and hardware offerings with consulting, deployment, and maintenance services to reduce implementation friction. Additionally, many companies are expanding their geographic footprint through localized partnerships and manufacturing arrangements to mitigate supply chain risks and comply with regional procurement requirements. Collectively, these strategic moves reflect a maturing competitive landscape in which differentiation is built on clinical validation, integration capabilities, and the ability to support complex enterprise requirements.

Actionable steps for healthcare leaders to align data governance, clinical validation, supply chain resilience, and workforce readiness for AI adoption

Industry leaders should adopt a pragmatic, evidence-driven roadmap that aligns technological investment with clinical priorities and operational constraints. First, prioritize data governance and interoperability initiatives to ensure high-quality, representative datasets and seamless integration with electronic health records and imaging systems. Next, design clinical validation studies that are pragmatic, reproducible, and embedded in care pathways so that results translate into actionable clinical adoption rather than isolated performance metrics. In procurement and supply chain planning, diversify sourcing and evaluate nearshoring options for critical hardware components while assessing the tariff sensitivities that could affect device availability and total cost of ownership.

Additionally, invest in workforce development and clinician engagement programs to build trust and fluency in AI-driven workflows; co-design interfaces with end users and pilot incrementally to gather feedback and iterate rapidly. From a security and compliance perspective, implement robust privacy preservation, auditing, and explainability features to meet regulatory expectations and support payer discussions. Consider hybrid deployment models to balance latency, control, and scalability while leveraging cloud partnerships for advanced analytics and model lifecycle management. Finally, pursue outcome-based contracts and evidence generation that demonstrate clinical and operational value, and maintain flexible commercial terms that accommodate organizational heterogeneity and evolving regulatory requirements.

A rigorous mixed-methods research approach integrating primary interviews, secondary literature, triangulation, segmentation mapping, and expert validation

This report synthesizes insights derived from a structured, methodical research approach combining primary and secondary sources, expert consultations, and iterative validation. Primary research included in-depth interviews with clinical leaders, technology executives, and supply chain managers to capture implementation realities and strategic priorities. Secondary research encompassed peer-reviewed literature, regulatory guidance documents, technical white papers, and vendor product literature to contextualize technological capabilities and evidence standards. Data triangulation techniques were used to reconcile differing perspectives and to identify consistent themes across sources.

Segmentation mapping was applied to classify technologies, delivery channels, data types, application areas, deployment modes, and end users, ensuring that analytic narratives remain aligned with real-world adoption scenarios. Qualitative analysis highlighted workflow integration challenges, clinician acceptance factors, and regulatory considerations, while thematic synthesis distilled recurring patterns around validation, interoperability, and commercialization. Validation rounds with independent subject-matter experts and clinicians refined the findings and ensured practical relevance. Constraints and limitations, including variations in regional regulatory regimes and heterogeneity in data quality, are acknowledged and factored into the interpretation of insights. Ethical considerations and data privacy protections informed the research design, and participant confidentiality was maintained throughout the study.

Synthesis of how evidence, interoperability, and cross-sector collaboration are essential to responsibly translate AI innovations into sustained clinical and operational impact

Artificial intelligence represents both a technological leap and an organizational challenge for healthcare. The most promising applications are those that demonstrably improve clinical decision-making, streamline administrative workflows, and enhance patient monitoring while aligning with regulatory and ethical frameworks. Adoption success depends on a combination of robust clinical evidence, seamless integration into clinician workflows, resilient supply chains, and forward-looking commercialization strategies. Regional regulatory differences and trade policy dynamics add layers of complexity but also create opportunities for localization and strategic partnerships.

As the ecosystem matures, stakeholders who focus on interoperable architectures, transparent validation practices, and patient-centric design will be best positioned to translate AI capabilities into measurable improvements in care delivery. Ultimately, the transition from pilot projects to sustained deployment requires sustained investment in data governance, clinician training, and outcome-oriented evidence generation. By following a disciplined, evidence-based approach and cultivating cross-sector collaborations, organizations can responsibly harness AI to deliver safer, more efficient, and more equitable healthcare.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Healthcare Market, by Type

  • 8.1. Hardware
    • 8.1.1. Monitoring Equipment
    • 8.1.2. Robotics
    • 8.1.3. Wearable Devices
  • 8.2. Services
    • 8.2.1. Consulting Services
    • 8.2.2. Deployment & Integration Services
    • 8.2.3. Maintenance & Support
  • 8.3. Software
    • 8.3.1. Clinical Decision Support Systems
    • 8.3.2. Data Management & Analysis
    • 8.3.3. Drug Discovery Platforms
    • 8.3.4. Medical Imaging Platforms
    • 8.3.5. Natural Language Processing Applications

9. Artificial Intelligence in Healthcare Market, by Delivery Channel

  • 9.1. Digital Platforms
  • 9.2. Onsite Services
  • 9.3. Remote Services

10. Artificial Intelligence in Healthcare Market, by Disease Category

  • 10.1. Cardiovascular Disorders
  • 10.2. Dermatological Disorders
  • 10.3. Gastrointestinal Disorders
  • 10.4. Neurological Disorders
  • 10.5. Oncology Disorders
  • 10.6. Orthopedic Disorders
  • 10.7. Respiratory Disorders

11. Artificial Intelligence in Healthcare Market, by Application

  • 11.1. Administrative Workflow
    • 11.1.1. Appointment Scheduling
    • 11.1.2. Billing Management
    • 11.1.3. Compliance Management
    • 11.1.4. Record Management
  • 11.2. Diagnostics
    • 11.2.1. Clinical Testing
    • 11.2.2. Genetic Testing
    • 11.2.3. Pathology Diagnostics
    • 11.2.4. Radiology Diagnostics
  • 11.3. Patient Monitoring
    • 11.3.1. ICU Monitoring
    • 11.3.2. Remote Patient Monitoring
    • 11.3.3. Vital Sign Monitoring
  • 11.4. Treatment Management
    • 11.4.1. Drug Therapy Optimization
    • 11.4.2. Personalized Medicine
    • 11.4.3. Radiation Therapy
    • 11.4.4. Robotic Surgery

12. Artificial Intelligence in Healthcare Market, by Deployment Mode

  • 12.1. Cloud-Based
  • 12.2. Hybrid
  • 12.3. On-Premise

13. Artificial Intelligence in Healthcare Market, by End-User

  • 13.1. Academic & Research Institutions
  • 13.2. Diagnostic Centers
  • 13.3. Hospitals & Healthcare Providers
  • 13.4. Pharmaceutical & Biotechnology Companies

14. Artificial Intelligence in Healthcare Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Artificial Intelligence in Healthcare Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Artificial Intelligence in Healthcare Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Artificial Intelligence in Healthcare Market

18. China Artificial Intelligence in Healthcare Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2024
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2024
  • 19.3. Product Portfolio Analysis, 2024
  • 19.4. Benchmarking Analysis, 2024
  • 19.5. Amazon Web Services, Inc.
  • 19.6. GE Healthcare
  • 19.7. Google, LLC by Alphabet, Inc.
  • 19.8. International Business Machines Corporation
  • 19.9. IQVIA Holdings Inc.
  • 19.10. Koninklijke Philips N.V.
  • 19.11. Microsoft Corporation
  • 19.12. Nano-X Imaging Ltd.
  • 19.13. Oracle Corporation
  • 19.14. Salesforce, Inc.
  • 19.15. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 14. CHINA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MONITORING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MONITORING EQUIPMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MONITORING EQUIPMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT & INTEGRATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT & INTEGRATION SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT & INTEGRATION SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING PLATFORMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING PLATFORMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING APPLICATIONS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING APPLICATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIGITAL PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIGITAL PLATFORMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIGITAL PLATFORMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONSITE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONSITE SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONSITE SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONCOLOGY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONCOLOGY DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONCOLOGY DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPOINTMENT SCHEDULING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPOINTMENT SCHEDULING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPOINTMENT SCHEDULING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY BILLING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY BILLING MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY BILLING MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COMPLIANCE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COMPLIANCE MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COMPLIANCE MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RECORD MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RECORD MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RECORD MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL TESTING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL TESTING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATHOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATHOLOGY DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATHOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIOLOGY DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ICU MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ICU MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ICU MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY VITAL SIGN MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY VITAL SIGN MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY VITAL SIGN MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG THERAPY OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG THERAPY OPTIMIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG THERAPY OPTIMIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIATION THERAPY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIATION THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTIC SURGERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTIC SURGERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HYBRID, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HOSPITALS & HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HOSPITALS & HEALTHCARE PROVIDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HOSPITALS & HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 163. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 165. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 166. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 167. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 169. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 171. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 175. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 176. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 177. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 178. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 179. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 181. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 183. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 185. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 187. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 189. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 191. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 192. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 193. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 195. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 197. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 199. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 201. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 203. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 204. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 205. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 206. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 207. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 237. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 239. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 241. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 243. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 245. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 246. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 247. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 248. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 249. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 251. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 253. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 254. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 255. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 257. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 259. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 260. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 261. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 262. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 263. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 268. ASIA-PAC